The changing landscape of treatment for acquired hemophilia A
Acquired hemophilia A (AHA) is a rare acquired autoimmune disorder caused by autoantibodies against coagulation factor VIII (FVIII), which cause a hemorrhagic diathesis, not rarely of severe degree. Standard treatment consists of bleeding control with bypassing agents (recombinant activated factor...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
PAGEPress Publications
2025-01-01
|
| Σειρά: | Bleeding, Thrombosis and Vascular Biology |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.btvb.org/btvb/article/view/157 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|